DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice

By Davis H.L.   Millan C.L.B.   Mancini M.   McCluskie M.J.   Hadchouel M.   Comanita L.   Tiollais P.   Whalen R.G.   Michel M.-L.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 849-852

Elsevier

Access to resources Recommend Favorite

False positive HBsAg result in blood donors due to administration of three different recombinant DNA Hepatitis B vaccines

By Otag F.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3734-3737

Elsevier

Access to resources Recommend Favorite

Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles

By Diminsky D.   Moav N.   Gorecki M.   Barenholz Y.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 3-17

Elsevier

Access to resources Recommend Favorite

Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine

By Netter H.J.   Woo W.-P.   Tindle R.   Macfarlan R.I.   Gowans E.J.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2692-2697

Elsevier

Access to resources Recommend Favorite

Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw 2 , adr, ayw 3 ) in measuring the immune response after vaccination

By Heijtink R.A.   Bergen P.v.   Melber K.   Janowicz Z.A.   Osterhaus A.D.M.E.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2191-2196

Elsevier

Access to resources Recommend Favorite